Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-07-30
1993-07-20
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514879, A61K 3144
Patent
active
052293947
ABSTRACT:
A method for treating ALS (Amyotrophic Lateral Sclerosis) is disclosed. The inventive method comprises the administration of controlled dosages of dextromethorphan in therapeutically effective amounts in a pharmaceutically acceptable vehicle Dextromethorphan (DMP) is a dimethylaminomethyl-substituted phenol, a sigma receptor antagonist known also as d-3-methoxy-N methylmorphinan, a d-isomer of the codeine analog, levorphanol. The inventive method has proven useful in controlling the progression of ALS in afflicted patients.
REFERENCES:
patent: 4806543 (1989-02-01), Choi
patent: 4888347 (1989-12-01), Woodruff et al.
Rowland, "Human Motor Neuron Diseases," Advances in Neurology, vol. 36, pp. 5-6 (1990).
Walker, S. O. et al. (1989), Clinical Neuropharmacology, vol. 12, pp. 322-330, 1989.
Gillberg, P. et al. Acta Neurol. Scand. 72:299-306 (1985).
Spencer, P. S. et al. Science 237:517-521 (1987).
ARCH Development Corporation
Hollinden Gary E.
Hollrah Glennon H.
LandOfFree
Method for treatment of amyotrophic lateral sclerosis comprising does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treatment of amyotrophic lateral sclerosis comprising, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treatment of amyotrophic lateral sclerosis comprising will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1760702